Nov 07, 2018 9:15 PM

VolitionRx Limited Announces Third Quarter 2018 Financial Results and Business Update

Oct 31, 2018 9:15 PM

VolitionRx Limited Schedules Third Quarter 2018 Earnings Conference Call and Business Update

Oct 04, 2018 2:15 PM

VolitionRx Limited to Expand its Nu.Q(TM) Trials to Veterinary Diagnostics

Sep 26, 2018 2:15 PM

VolitionRx Limited Releases Video Featuring Interviews with its Scientific Advisory Board

Aug 13, 2018 9:15 PM

VolitionRx Limited Announces Second Quarter 2018 Financial Results and Business Update

Aug 13, 2018 2:15 PM

Preliminary Data from Study Demonstrates 94% Accuracy in Detecting Aggressive Prostate Cancer

Aug 09, 2018 2:15 PM

VolitionRx Limited Announces Completion of Sample Collection in Endometriosis Study

Aug 08, 2018 11:15 AM

VolitionRx Announces $9 Million Private Placement

Aug 07, 2018 2:15 PM

VolitionRx Limited Schedules Second Quarter 2018 Earnings Conference Call and Business Update

Aug 01, 2018 12:15 PM

VolitionRx's First Research Use Only Product Is "On-The-Shelf" Today

Jul 10, 2018 2:15 PM

Volition Extends Global Reach of its Clinical Trial Program

Jul 02, 2018 2:15 PM

Volition Secures Additional $700,000 Non-Dilutive Funding from the Walloon Region

May 14, 2018 2:15 PM

VolitionRx Limited to Attend the Bank of America Merrill Lynch 2018 Health Care Conference from May 15-17, 2018

May 10, 2018 9:15 PM

VolitionRx Limited Announces First Quarter 2018 Financial Results and Business Update

May 09, 2018 4:13 PM

VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits

May 08, 2018 5:09 PM

VolitionRx Limited Schedules First Quarter 2018 Earnings Conference Call and Business Update

Mar 13, 2018 9:00 PM

VolitionRx Announces Closing of $8.4 Million Public Offering of Common Stock

Mar 09, 2018 3:00 PM

VolitionRx Announces Pricing of $8.4 Million Public Offering of Common Stock

Mar 08, 2018 10:00 PM

VolitionRx Announces Proposed Underwritten Public Offering of Common Stock

Mar 07, 2018 2:00 PM

VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board

Mar 01, 2018 10:00 PM

VolitionRX Limited Announces Full Fiscal Year 2017 Financial Results and Business Update

Feb 28, 2018 10:00 PM

VolitionRx Limited Schedules Full Year 2017 Earnings Conference Call and Business Update

Feb 26, 2018 10:00 PM

VolitionRx Limited Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer

Feb 05, 2018 2:00 PM

VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark.

Jan 03, 2018 2:00 PM

Press Releases